Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem P Brouwer

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide for hepatitis B: evolution or revolution?Willem P Brouwer
Blood Purification|December 22, 2020
Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival AnalysisWillem P Brouwer, Servet Duran, Can Ince
Hepatology (Baltimore, Md.)|June 19, 2012
Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotypeMilan J Sonneveld, Willem P Brouwer, Harry L A Janssen
Gastroenterology|March 30, 2016
Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B?Milan J Sonneveld, Willem P Brouwer, Adriaan J van der Meer
Journal of Clinical and Experimental Hepatology|March 17, 2025
Diagnostic Accuracy of the LiverRisk Score to Detect Increased Liver Stiffness Among a United States General Population and SubgroupsLaurens A van Kleef, Jesse Pustjens, Harry L A Janssen, et al.
Alimentary Pharmacology & Therapeutics|December 17, 2020
Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis-authors' replyMilan J Sonneveld, Willem P Brouwer, Robert A de Man, et al.
World Journal of Gastroenterology|September 30, 2025
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populationsJesse Pustjens, Willem P Brouwer, Ibrahim Ayada, et al.
Hepatology (Baltimore, Md.)|October 9, 2019
ReplyHannah S J Choi, Willem P Brouwer, Bettina E Hansen, et al.
JHEP Reports : Innovation in Hepatology|December 6, 2024
Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLDJesse Pustjens, Laurens A van Kleef, Harry L A Janssen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2025
FIB-4-based Referral Pathways Have Suboptimal Accuracy to identify Increased Liver Stiffness and Incident Advanced Liver DiseaseLaurens A van Kleef, Rickard Strandberg, Jesse Pustjens, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide for hepatitis B: evolution or revolution?Willem P Brouwer
Blood Purification|December 22, 2020
Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival AnalysisWillem P Brouwer, Servet Duran, Can Ince
Hepatology (Baltimore, Md.)|June 19, 2012
Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotypeMilan J Sonneveld, Willem P Brouwer, Harry L A Janssen
Gastroenterology|March 30, 2016
Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B?Milan J Sonneveld, Willem P Brouwer, Adriaan J van der Meer
Journal of Clinical and Experimental Hepatology|March 17, 2025
Diagnostic Accuracy of the LiverRisk Score to Detect Increased Liver Stiffness Among a United States General Population and SubgroupsLaurens A van Kleef, Jesse Pustjens, Harry L A Janssen, et al.
Alimentary Pharmacology & Therapeutics|December 17, 2020
Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis-authors' replyMilan J Sonneveld, Willem P Brouwer, Robert A de Man, et al.
World Journal of Gastroenterology|September 30, 2025
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populationsJesse Pustjens, Willem P Brouwer, Ibrahim Ayada, et al.
Hepatology (Baltimore, Md.)|October 9, 2019
ReplyHannah S J Choi, Willem P Brouwer, Bettina E Hansen, et al.
JHEP Reports : Innovation in Hepatology|December 6, 2024
Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLDJesse Pustjens, Laurens A van Kleef, Harry L A Janssen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2025
FIB-4-based Referral Pathways Have Suboptimal Accuracy to identify Increased Liver Stiffness and Incident Advanced Liver DiseaseLaurens A van Kleef, Rickard Strandberg, Jesse Pustjens, et al.
Pageof 5